Real-world Evidence of COVID-19 Vaccines Effectiveness

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT04981405

Recruitment Status : Terminated (low recruitment, end of COVID-19 pandemic)

First Posted : July 29, 2021

Last Update Posted : July 22, 2022

View this study on Beta.ClinicalTrials.gov

Sponsor:

Collaborators:

European University at St. Petersburg

Medical Institute named after Berezin Sergey

Information provided by (Responsible Party):

Ivan S Moiseev, St. Petersburg State Pavlov Medical University

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Terminated
Actual Primary Completion Date :	July 19, 2022
Actual Study Completion Date :	July 19, 2022

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Barchuk A, Bulina A, Cherkashin M, Berezina N, Rakova T, Kuplevatskaya D, Skougarevskiy D, Okhotin A. Gam-COVID-Vac, EpiVacCorona, and CoviVac effectiveness against lung injury during Delta and Omicron variant surges in St. Petersburg, Russia: a test-negative case-control study. Respir Res. 2022 Oct 10;23(1):276. doi: 10.1186/s12931-022-02206-3.

To Top